natgillin/translations-raw huggingface dataset:
On 2 February 2018, the Applicant made a request to the Commission for the protection of proprietary data for a number of studies submitted in support of the application namely, a de novo peptide synthesis study, the analytical report of the ACE inhibitory effects study, an acute oral toxicity study, an in vitro bacterial reverse mutation assay, a 90-day oral toxicity study, an assessment study of the antihypertensive effects and safety of the refined shrimp peptide concentrate in healthy humans with mild or moderate hypertension, and a double-blind, placebo-controlled, parallel study on the assessment of anti-hypertensive effect and safety of a the refined shrimp peptide concentrate in dietary supplements in healthy humans with mild or moderate hypertension.
Podnositelj zahtjeva Komisiji je 2. veljače 2018. podnio zahtjev za zaštitu vlasnički zaštićenih podataka za niz studija koje je dostavio u potporu zahtjevu, i to de novo studiju sinteze peptida, analitičko izvješće o ispitivanju inhibitornih učinaka ACE-a, studiju akutne oralne toksičnosti, bakterijski test povratnih mutacija in vitro, 90-dnevnu studiju oralne toksičnosti, studiju o ocjeni antihipertenzijskih učinaka i sigurnosti rafiniranog koncentrata peptida kozice kod zdravih osoba s blagom ili umjerenom hipertenzijom te studiju o dvostruko slijepom placebom kontroliranom paralelnom ispitivanju za ocjenu antihipertenzijskog učinka i sigurnosti rafiniranog koncentrata peptida kozice u dodacima prehrani kod zdravih osoba s blagom ili umjerenom hipertenzijom.
This request was reiterated by the Applicant in a subsequent application submitted on 29 March 2018.
Taj je zahtjev podnositelj zahtjeva ponovio u naknadnom zahtjevu podnesenom 29. ožujka 2018.
On 18 April 2018, the Authority adopted ‘Scientific Opinion on the safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283’.
Agencija je 18. travnja 2018. donijela „Znanstveno mišljenje o sigurnosti rafiniranog koncentrata peptida kozice kao nove hrane u skladu s Uredbom (EU) 2015/2283”.
That opinion is in line with the requirements of Article 11 of Regulation (EU) 2015/2283.
To je mišljenje u skladu sa zahtjevima članka 11. Uredbe (EU) 2015/2283.
That opinion gives sufficient grounds to establish that refined shrimp peptide concentrate, in the proposed uses and use levels when used as an ingredient in food supplements, complies with Article 12(1) of Regulation (EU) 2015/2283.
U mišljenju se iznosi dovoljno informacija na temelju kojih se može utvrditi da je rafinirani koncentrat peptida kozice u skladu s člankom 12. stavkom 1. Uredbe (EU) 2015/2283 kada se upotrebljava kao sastojak u dodacima prehrani u predloženim upotrebama i količinama.
In its opinion, the Authority considered that the data from the 90-day oral toxicity study served as a basis to assess the toxicity profile of refined shrimp peptide concentrate and to establish the related No Observed Adverse Effect Level (NOAEL).
U svojem mišljenju Agencija smatra da su podaci iz 90-dnevne studije oralne toksičnosti upotrijebljeni kao osnova za ocjenu profila toksičnosti rafiniranog koncentrata peptida kozice i utvrđivanje povezane količine bez opaženog štetnog učinka (NOAEL).
The data from the assessment study of the antihypertensive effects and safety of the refined shrimp peptide concentrate in healthy humans with mild or moderate hypertension, and the data from the double-blind, placebo-controlled, parallel study on the assessment of anti-hypertensive effect and safety of a the refined shrimp peptide concentrate dietary supplement in healthy humans with mild or moderate hypertension, served as the basis to establish the safety of the novel food for this category of consumers.
Podaci iz studije o ocjeni antihipertenzijskih učinaka i sigurnosti rafiniranog koncentrata peptida kozice kod zdravih osoba s blagom ili umjerenom hipertenzijom te podaci iz studije o dvostruko slijepom placebom kontroliranom paralelnom ispitivanju za ocjenu antihipertenzijskog učinka i sigurnosti dodatka prehrani rafinirani koncentrat peptida kozice kod zdravih osoba s blagom ili umjerenom hipertenzijom, upotrijebljeni su kao osnova za utvrđivanje sigurnosti nove hrane za tu kategoriju potrošača.
Therefore, it is considered that the conclusions on the safety of refined shrimp peptide concentrate, could not have been reached without the data from the unpublished reports of these studies.
Stoga se smatra da zaključci o sigurnosti rafiniranog koncentrata peptida kozice ne bi mogli biti doneseni bez podataka iz neobjavljenih izvješća o tim studijama.
Following receipt of the Authority's opinion, the Commission requested the Applicant to further clarify the justification provided with regard to their proprietary claim over the study reports, and to clarify their claim to an exclusive right of reference to those studies, as referred to in points (a) and (b) of Article 26(2) of Regulation (EU) 2015/2283.
Nakon primitka mišljenja Agencije Komisija je zatražila od podnositelja zahtjeva da dodatno pojasni dano obrazloženje u pogledu njegova zahtjeva za zaštitu vlasničkih podataka iz izvješća o studijama i da pojasni zahtjev za isključivo pravo upućivanja na te studije, kako je navedeno u članku 26. stavku 2. točkama (a) i (b) Uredbe (EU) 2015/2283.
The Applicant also declared to hold proprietary and exclusive rights of reference to the studies under national law at the time the application was submitted, and that therefore third parties could not lawfully access or use those studies.
Podnositelj zahtjeva izjavio je i da je u trenutku podnošenja zahtjeva bio nositelj vlasničkih i isključivih prava upućivanja na studije u skladu s nacionalnim pravom te da stoga treće osobe nisu mogle imati zakonit pristup tim studijama niti se koristiti njima.
The Commission has assessed all the information provided by the Applicant and considers that the Applicant has sufficiently substantiated the fulfilment of the requirements laid down in Article 26(2) of Regulation (EU) 2015/2283.
Komisija je ocijenila sve informacije koje je dostavio podnositelj zahtjeva te zaključila da je podnositelj zahtjeva dostatno potkrijepio ispunjenje zahtjeva utvrđenih u članku 26. stavku 2. Uredbe (EU) 2015/2283.
Accordingly, as provided for under Article 26(2) of Regulation (EU) 2015/2283, the 90-day oral toxicity study, the assessment study of the antihypertensive effects and safety of the refined shrimp peptide concentrate in healthy humans with mild or moderate hypertension, and the double-blind, placebo-controlled, parallel study on the assessment of anti-hypertensive effect and safety of a the refined shrimp peptide concentrate dietary supplement in healthy humans with mild or moderate hypertension, contained in the Applicant's file and without which the novel food could not have been assessed by the Authority, should not be used by the Authority for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation.
U skladu s tim, kako je predviđeno u članku 26. stavku 2. Uredbe (EU) 2015/2283, Agencija 90-dnevnu studiju oralne toksičnosti, studiju o ocjeni antihipertenzijskih učinaka i sigurnosti rafiniranog koncentrata peptida kozice kod zdravih osoba s blagom ili umjerenom hipertenzijom i studiju o dvostruko slijepom placebom kontroliranom paralelnom ispitivanju za ocjenu antihipertenzijskog učinka i sigurnosti dodatka prehrani rafinirani koncentrat peptida kozice kod zdravih osoba s blagom ili umjerenom hipertenzijom, koje su sadržane u dokumentaciji podnositelja zahtjeva i bez kojih Agencija ne bi mogla ocijeniti novu hranu, ne bi smjela upotrijebiti u korist budućeg podnositelja zahtjeva tijekom razdoblja od pet godina od datuma stupanja na snagu ove Uredbe.
As a consequence, the placing on the market within the Union of the novel food authorised by this Regulation should be restricted to the Applicant for a period of five years.
Slijedom toga, stavljanje na tržište u Uniji nove hrane odobrene ovom Uredbom trebalo bi ograničiti na podnositelja zahtjeva tijekom razdoblja od pet godina.
However, restricting the authorisation of this novel food and of the reference to the 90-day oral toxicity study, to the assessment study of the antihypertensive effects and safety of the refined shrimp peptide concentrate in healthy humans with mild or moderate hypertension, and to the double-blind, placebo-controlled, parallel study on the assessment of anti-hypertensive effect and safety of a the refined shrimp peptide concentrate dietary supplement in healthy humans with mild or moderate hypertension, contained in the Applicant's file for the sole use of the Applicant does not prevent other applicants from applying for an authorisation to place on the market the same novel food provided that their application is based on legally obtained information supporting the authorisation under this Regulation.
Međutim, ograničenje upotrebe odobrenja te nove hrane i upućivanja na 90-dnevnu studiju oralne toksičnosti, na studiju o ocjeni antihipertenzijskih učinaka i sigurnosti rafiniranog koncentrata peptida kozice kod zdravih osoba s blagom ili umjerenom hipertenzijom i na studiju o dvostruko slijepom placebom kontroliranom paralelnom ispitivanju za ocjenu antihipertenzijskog učinka i sigurnosti dodatka prehrani rafinirani koncentrat peptida kozice kod zdravih osoba s blagom ili umjerenom hipertenzijom, koje su sadržane u dokumentaciji podnositelja zahtjeva, isključivo na podnositelja zahtjeva ne sprečava druge podnositelje zahtjeva da podnesu zahtjev za odobrenje stavljanja na tržište iste nove hrane pod uvjetom da se njihov zahtjev temelji na zakonito pribavljenim informacijama koje podupiru odobrenje u skladu s ovom Uredbom.
As the source of the novel food comes from crustaceans, and may contain traces of fish, of other crustaceans, and of molluscs, which are listed in Annex II to Regulation (EU) No 1169/2011 of the European Parliament and of the Council as substances or products which cause allergies or intolerances, food supplements containing refined shrimp peptide concentrate should be appropriately labelled following the requirements of Article 21 of that Regulation.
Budući da se nova hrana dobiva od rakova i može sadržavati tragove ribe, drugih rakova i mekušaca, koji su navedeni u Prilogu II. Uredbi (EU) br. 1169/2011 Europskog parlamenta i Vijeća kao tvari ili proizvodi koji uzrokuju alergije ili netolerancije, dodatke prehrani koji sadržavaju rafinirani koncentrat peptida kozice trebalo bi na odgovarajući način označiti u skladu sa zahtjevima članka 21. te uredbe.
Directive 2002/46/EC of the European Parliament and of the Council lays down requirements on food supplements.
Direktivom 2002/46/EZ Europskog parlamenta i Vijeća utvrđeni su zahtjevi o dodacima prehrani.
The use of refined shrimp peptide concentrate should be authorised without prejudice to that Directive.
Upotrebu rafiniranog koncentrata peptida kozice trebalo bi odobriti ne dovodeći u pitanje tu direktivu.
Refined shrimp peptide concentrate as specified in the Annex to this Regulation shall be included in the Union list of authorised novel foods established in Implementing Regulation (EU) 2017/2470.
Rafinirani koncentrat peptida kozice, kako je naveden u Prilogu ovoj Uredbi, uvrštava se na Unijin popis odobrene nove hrane utvrđen u Provedbenoj uredbi (EU) 2017/2470.
For a period of five years from the date of entry into force of this Regulation only the initial Applicant:
Tijekom razdoblja od pet godina od datuma stupanja na snagu ove Uredbe isključivo je prvotnom podnositelju zahtjeva,
Company: Marealis AS;
društvu: Marealis AS,
Address: Stortorget 1, Kystens Hus, 2nd floor, N-9008 Tromsø Postal address: P.O. Box 1065, 9261 Tromsø, Norway
Adresa: Stortorget 1, Kystens Hus, 2nd floor, N–9008 Tromsø. Poštanska adresa: P.O.
is authorised to place on the market within the Union the novel food referred to in paragraph 1, unless a subsequent applicant obtains authorisation for the novel food without reference to the data protected pursuant to Article 2 of this Regulation or with the agreement of Marealis AS.
odobreno stavljati na tržište u Uniji novu hranu iz stavka 1., osim ako budući podnositelj zahtjeva dobije odobrenje za novu hranu bez upućivanja na podatke zaštićene u skladu s člankom 2. ove Uredbe ili uz suglasnost društva Marealis AS.
The entry in the Union list referred to in paragraph 1 shall include the conditions of use and labelling requirements laid down in the Annex to this Regulation
Unos na Unijin popis iz stavka 1. uključuje uvjete upotrebe i zahtjeve za označivanje utvrđene u Prilogu ovoj Uredbi.
The authorisation provided for in this Article shall be without prejudice to the provisions of Directive 2002/46/EC and to the provisions of Regulation (EU) No 1169/2011.
Odobrenjem iz ovog članka ne dovode se u pitanje odredbe Direktive 2002/46/EZ i odredbe Uredbe (EU) br. 1169/2011.
The studies contained in the application file on the basis of which the novel food referred to in Article 1 has been assessed by the Authority, claimed by the Applicant as fulfilling the requirements laid down in Article 26(2) of Regulation (EC) No 2015/2283, shall not be used for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation without the agreement of Marealis AS.
Studije iz dokumentacije podnositelja zahtjeva na temelju kojih je Agencija ocijenila novu hranu iz članka 1., i za koje podnositelj zahtjeva tvrdi da ispunjavaju zahtjeve utvrđene u članku 26. stavku 2. Uredbe 2015/2283, ne smiju se upotrebljavati u korist budućih podnositelja zahtjeva tijekom razdoblja od pet godina od datuma stupanja na snagu ove Uredbe bez suglasnosti društva Marealis AS.
Marealis A.S., 2009-2016.
Marealis A.S., 2009.–2016.
EFSA Journal 2018; 16(5):5267.
EFSA Journal 2018.; 16(5):5267.
the following last column is added in Table 1 (Authorised novel foods):
Sljedeći zadnji stupac dodaje se u tablicu 1. (Odobrena nova hrana):
‘Refined shrimp peptide concentrate
„Rafinirani koncentrat peptida kozice
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘refined shrimp peptide concentrate’.
Pri označivanju hrane koja sadržava novu hranu navodi se ‚rafinirani koncentrat peptida kozice’.
Applicant: Marealis AS., Stortorget 1, Kystens Hus, 2nd floor, N-9008 Tromsø Postal address: P.O. Box 1065, 9261 Tromsø, Norway
Podnositelj zahtjeva: Marealis AS., Stortorget 1, Kystens Hus, 2nd floor, N–9008 Tromsø. Poštanska adresa: P.O. Box 1065, 9261 Tromsø, Norveška
During the period of data protection the novel food refined shrimp peptide concentrate is authorised for placing on the market within the Union only by Marealis AS unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Marealis AS.
Tijekom razdoblja zaštite podataka stavljanje na tržište u Uniji nove hrane rafinirani koncentrat peptida kozice odobreno je isključivo podnositelju zahtjeva Marealis AS, osim ako budući podnositelj zahtjeva dobije odobrenje za novu hranu bez upućivanja na vlasnički zaštićene znanstvene dokaze ili znanstvene podatke zaštićene u skladu s člankom 26. Uredbe (EU) 2015/2283 ili uz suglasnost društva Marealis AS.
Refined shrimp peptide concentrate is a peptide mixture obtained from northern shrimp (Pandalus borealis) shells and heads via a series of purification steps following enzymatic proteolysis using a protease from Bacillus licheniformis and/or Bacillus amyloliquefaciens.
Rafinirani koncentrat peptida kozice je smjesa peptida dobivena od ljuštura i glava sjeverne kozice (Pandalus borealis) nizom postupaka pročišćavanja nakon enzimske proteolize s pomoću proteaze bakterija Bacillus licheniformis i/ili Bacillus amyloliquefaciens.
Total Dry matter (%): ≥ 95,0 %
Ukupna suha tvar (%): ≥ 95,0 %
Peptides (w/weight dry matter): ≥ 87,0 % of which peptides with molecular weight < 2 kDa: ≥ 99,9 %
Peptidi (m/m suhe tvari) ≥ 87,0 % od čega peptidi molekularne mase < 2 kDa: ≥ 99,9 %
Fat (w/w): ≤ 1,0 %
Masti (m/m): ≤ 1,0 %
Carbohydrates (w/w): ≤ 1,0 %
Ugljikohidrati (m/m): ≤ 1,0 %
Ash (w/w): ≤ 15,0 %
Pepeo (m/m): ≤ 15,0 %
Calcium: ≤ 2,0 %
Kalcij: ≤ 2,0 %
Potassium: ≤ 0,15 %
Kalij: ≤ 0,15 %
Sodium: ≤ 3,5 %
Natrij: ≤ 3,5 %
Arsenic (inorganic): ≤ 0,22 mg/kg
Arsen (anorganski): ≤ 0,22 mg/kg
Arsenic (organic): ≤ 51,0 mg/kg
Arsen (organski): ≤ 51,0 mg/kg
Cadmium: ≤ 0,09 mg/kg
Kadmij: ≤ 0,09 mg/kg
Lead: ≤ 0,18 mg/kg
Olovo: ≤ 0,18 mg/kg
Total mercury: ≤ 0,03 mg/kg
Ukupna živa: ≤ 0,03 mg/kg
Total viable cell count: ≤ 20000 CFU/g
Ukupan broj živih stanica: ≤ 20000 CFU/g
Salmonella: ND/25g
Salmonella: ND/25 g
Listeria monocytogenes: ND/25g
Listeria monocytogenes: ND/25 g
Coagulase positive Staphylococcus aureus: ≤ 200 CFU/g
Koagulaza-pozitivni Staphylococcus aureus: ≤ 200 CFU/g
Pseudomonas aeruginosa: ND/25g
Pseudomonas aeruginosa: ND/25 g
Mould/yeast: ≤ 20 CFU/g
Plijesan/kvasac: ≤ 20 CFU/g
CFU : Colony Forming Units
CFU : jedinice koje tvore kolonije
ND : Not Detectable’
ND : Ne može se utvrditi”
Sarkkinen, E., et al. 2013.
Sarkkinen, E., i dr. 2013.
Commission Implementing Regulation (EU) 2018/1634
Provedbena uredba Komisije (EU) 2018/1634
Article 13(1) of Regulation (EC) No 1967/2006 prohibits the use of towed gears within 3 nautical miles of the coast or within the 50 m isobaths where that depth is reached at a shorter distance from the coast.
Člankom 13. stavkom 1. Uredbe (EZ) br. 1967/2006 zabranjena je upotreba povlačnih alata unutar 3 morske milje od obale ili unutar izobate od 50 m ako se ta dubina dosegne na kraćoj udaljenosti od obale.
A derogation from Article 13(1) of that Regulation for the use of boat seines by vessels fishing for transparent goby (Aphia minuta) in the territorial waters of the Geographical Sub-Area 9, as defined in Annex I to Regulation (EU) No 1343/2011 of the European Parliament and of the Council was granted until 31 March 2014 by Commission Implementing Regulation (EU) No 988/2011.
Odstupanje od članka 13. stavka 1. te uredbe u pogledu potegača otvorenog mora koje upotrebljavaju plovila koja love mliječ ružični (Aphia minuta) u teritorijalnim vodama geografskog potpodručja 9, kako je utvrđeno u Prilogu I. Uredbi (EU) br. 1343/2011 Europskog parlamenta i Vijeća, bilo je odobreno do 31. ožujka 2014. Provedbenom uredbom Komisije (EU) br. 988/2011.
An extension of the derogation was granted until 31 March 2018 by Commission Implementing Regulation (EU) 2015/2407.
Provedbenom uredbom Komisije (EU) 2015/2407 odobreno je produljenje tog odstupanja do 31. ožujka 2018.
The management plan adopted is put in place to accompany the entire duration of the derogation.
Doneseni plan upravljanja primjenjuje se tijekom čitavog trajanja odstupanja.
The Scientific, Technical and Economic Committee for Fisheries (STECF) assessed the derogation requested by Italy and the related updated management plan in July 2018.
Znanstveni, tehnički i gospodarski odbor za ribarstvo (STECF) u srpnju 2018. ocijenio je odstupanje koje je zatražila Italija, zajedno s pripadajućim ažuriranim planom upravljanja.
The overall assessment by the STECF is positive, information on its biology and ecology, fleet and effort are well presented.
Ukupna je ocjena STECF-a pozitivna; informacije o biologiji, ekologiji, floti i naporu dobro su predstavljene.
STECF stated that the objectives proposed by the management plan are consistent with the objectives of Article 2 of Regulation (EU) No 1380/2013 of the European Parliament and of the Council and with the relevant provisions of Article 6.
STECF je izjavio da su ciljevi koji se predlažu u planu upravljanja u skladu s ciljevima iz članka 2. Uredbe (EU) br. 1380/2013 Europskog parlamenta i Vijeća i u skladu s odgovarajućim odredbama članka 6.
The presence of other species in the catches is quite occasional.
Prisutnost drugih vrsta u ulovu prilično je rijetka.
The boat-seine for transparent goby can be considered as selective gear while for species from the Annex III of Regulation (EC) No 1967/2006 the impact of this boat seine on these species can be considered as very low.
Potegača otvorenog mora za mliječ ružični može se smatrati selektivnim alatom, dok se njezin učinak na vrste iz Priloga III. Uredbi (EZ) br. 1967/2006 može smatrati vrlo ograničenim.
STECF stated that the management plan contains a lot of elements for the monitoring and management of the fishing activities.
STECF je izjavio da plan upravljanja sadržava mnogo elemenata za praćenje ribolovnih aktivnosti i upravljanje njima.
STECF highlighted the need for some clarifications on gears interaction on seabed, monitoring and scientific data.
STECF je naglasio potrebu za određenim objašnjenjima o međudjelovanju alata na morsko dno, praćenju i znanstvenim podacima.
Italy was requested to examine these issues.
Od Italije je zatraženo da prouči ta pitanja.
In order to address the issue of improved scientific data, the Italian authorities agreed to update the management plan and re-enforce the compulsory reporting obligations with the commitment to provide preliminary scientific report at the end of the 2019-2020 fishing season.
Kako bi se odgovorilo na pitanje poboljšanja znanstvenih podataka, talijanska tijela složila su se da će ažurirati plan upravljanja i pojačati obvezno izvješćivanje tako što će se obvezati na dostavu preliminarnog znanstvenog izvješća na kraju ribolovne sezone 2019.–2020.
The extension of the derogation requested by Italy complies with the conditions laid down in Article 13(5) and (9) of Regulation (EC) No 1967/2006.
Produljenje odstupanja koje je zatražila Italija ispunjuje uvjete iz članka 13. stavaka 5. i 9. Uredbe (EZ) br. 1967/2006.
There are specific geographical constraints given both the limited size of the continental shelf and the spatial distribution of the target species, which is exclusively limited to certain zones in the coastal areas at depths smaller than 50 m. Hence, the fishing grounds are limited.
Postoje posebna zemljopisna ograničenja s obzirom na ograničenu veličinu epikontinentalnog pojasa i prostorni raspored ciljane vrste, koja je ograničena isključivo na određene dijelove obalnih područja na dubinama manjima od 50 m. Stoga je ribolovno područje ograničeno.
STECF expressed some concerns on the lack of updated data on spatial distribution of fishing operations in relation to the distribution of the seagrass habitats.
STECF je izrazio određenu zabrinutost zbog nedostatka ažuriranih podataka o prostornoj rasprostranjenosti ribolovnih operacija u vezi s rasprostranjenošću staništa morskih cvjetnica.
However, it should be noted that with respect to the impact on the seabed, the observations carried out on board during the fishing seasons have shown that the boat-seine operates effectively only on the clean seabed, made of sand or mud while fishing is prohibited over Posidonia beds.
Međutim, valja napomenuti da su s obzirom na utjecaj na morsko dno promatranja provedena na plovilima tijekom ribolovne sezone pokazala da potegača otvorenog mora učinkovito djeluje samo na čistom, pješčanom ili blatnom morskom dnu, dok je na morskom dnu na kojem raste Posidonia ribolov zabranjen.
Account taken of the above, it is concluded that boat seines fishing has no significant impact on protected habitats and is very selective, since the seines are hauled in the water column and do not touch the seabed because collection of material from the seabed would damage the target species and make the selection of the fished species virtually impossible due to their very small size.
S obzirom na prethodno navedeno zaključeno je da ribolov potegačama otvorenog mora nema znatan utjecaj na zaštićena staništa i da je vrlo selektivan s obzirom na to da se potegače izvlače u vodenom stupcu i ne dodiruju morsko dno jer bi prikupljeni materijal s morskog dna oštetio ciljane vrste i gotovo onemogućio selekciju ulovljenih vrsta zbog njihove izrazito male veličine.